BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16647748)

  • 21. Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer.
    Lin LL; Grigsby PW; Powell MA; Mutch DG
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):500-4. PubMed ID: 16168841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intensity modulated radiation therapy for patients with gynecological malignancies after hysterectomy and chemotherapy/radiotherapy].
    Chen ZY; Ma YB; Sheng XG; Zhang XL; Xue L; Song QQ; Liu NF; Miao HQ
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):305-8. PubMed ID: 17760262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancer.
    Barney BM; MacDonald OK; Lee CM; Rankin J; Gaffney DK
    Brachytherapy; 2007; 6(3):201-6. PubMed ID: 17681241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome.
    Beriwal S; Heron DE; Kim H; King G; Shogan J; Bahri S; Gerszten K; Lee J; Kelley J; Edwards RP
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1395-400. PubMed ID: 16442238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis.
    McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy.
    Weiss E; Hirnle P; Arnold-Bofinger H; Hess CF; Bamberg M
    Gynecol Oncol; 1998 Oct; 71(1):72-6. PubMed ID: 9784322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
    Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients.
    Röper B; Astner ST; Heydemann-Obradovic A; Thamm R; Jacob V; Hölzel D; Schmalfeldt B; Kiechle-Bahat M; Höss C; Molls M
    Gynecol Oncol; 2007 Dec; 107(3):541-8. PubMed ID: 17884152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
    Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
    Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma.
    Fayed A; Mutch DG; Rader JS; Gibb RK; Powell MA; Wright JD; Elnaqa I; Zoberi I; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):480-4. PubMed ID: 17141980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
    Khor TH; Tuan JK; Hee SW; Tham IW
    Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.
    Chong I; Hoskin PJ
    Brachytherapy; 2008; 7(2):195-9. PubMed ID: 18358790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer.
    Solhjem MC; Petersen IA; Haddock MG
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1379-84. PubMed ID: 16029796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
    Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
    Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS
    Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
    Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update.
    Madani I; Bonte K; Vakaet L; Boterberg T; De Neve W
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):424-32. PubMed ID: 18755554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
    Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes.
    Cahlon O; Zelefsky MJ; Shippy A; Chan H; Fuks Z; Yamada Y; Hunt M; Greenstein S; Amols H
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):330-7. PubMed ID: 18164858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.